Clinical trial
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating…
NCT00449020 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00449020 |
|---|---|
| Title | Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer |
| Official title | Carboplatin and Irinotecan Concomitantly With Radiation Therapy Followed by Consolidation Chemotherapy With Docetaxel for Locally Advanced Non-Small Cell Lung Cancer (GIA 12177). |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Carboplatin, Docetaxel, irinotecan hydrochloride, radiation therapy |
| Enrollment | 32 |
| Start date | Jan 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Mar 19, 2007 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: